BofA raised the firm’s price target on UnitedHealth (UNH) to $390 from $350 and keeps a Neutral rating on the shares. UnitedHealth’s implied roughly $17 guidance for 2026 EPS is less than half of the $35 investors expected just 12 months ago, notes the analyst, who estimates 2028 earnings power of $24-$37 per share. Until getting more clarity on the potential for a 2027 coding adjustment, the firm remain Neutrals, but sees significant upside potential if rates aren’t a headwind, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth price target raised to $400 from $350 at KeyBanc
- UnitedHealth’s Earnings Outlook: Balancing Potential Upside with Uncertainty
- UnitedHealth price target raised to $400 from $267 at Wells Fargo
- UNH vs. LLY vs. HIMS: Which Healthcare Stock Is the Best Pick, According to Analysts?
- UnitedHealth Group Stock Forecast: AI Analyst Backs Bullish Case for UNH